Falini et al[1][1] first reported exon 12 mutations in the nucleophosmin ( NPM1 ) gene in approximately 35% of patients with adult acute myeloid leukemia (AML). These mutations disrupt the nucleolar-localization signal and acquire a nuclear export signal motif at the C-terminus leading to abnormal
No takes yet. Share an insight, caveat, or question.
Chen et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: